In expansive retrospective analysis, studies from these regions have validated AFP, AFP-L3, and DCP levels as risk factors for recurrence post-resection as well as recurrence-free survival outcomes across the spectrum of non-surgical, locally advanced, and intermediate to advanced HCC [9,10,11,12,13,14,15,16,17]. This evidence concerns the gene AFP and hepatocellular carcinoma.